Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesEmotion-elicited gamma synchrony in patients with first-episode schizophrenia: a neural correlate of social cognition outcomes
Journal of Psychiatry & Neuroscience , 07/01/09
Williams LM et al. - The findings suggest that disruptions in integrative processing of motivationally important stimuli show promise as a potential biological marker of social cognitive impairments, present from the first episode of schizophrenia, and their outcomes.
Related Articles
Auditory gating deficit to human voices in schizophrenia: A MEG study
Schizophrenia Research, 10/01/09
Relevance Score: 93%
Age at onset and cognition in schizophrenia: meta-analysis
British Journal of Psychiatry, 10/06/09
Relevance Score: 92%
Beyond symptom dimensions: Schizophrenia risk factors for patient groups derived by latent class analysis
Schizophrenia Research, 10/30/09
Relevance Score: 91%
Functional Magnetic Resonance Imaging of Inner Speech in Schizophrenia
Biological Psychiatry, 10/26/09
Relevance Score: 91%
Sensory Processing in Schizophrenia: Neither Simple nor Intact
Schizophrenia Bulletin, 10/19/09
Relevance Score: 91%
Today in Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
What drives referral from primary care physicians to mental health specialists? A randomized trial using actors portraying depressive symptoms
Journal of General Internal Medicine, 12/07/09
Using the patient health questionnaire-9 to measure depression among racially and ethnically diverse primary care patients
Journal of General Internal Medicine, 12/07/09
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial
Schizophrenia Research, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor